$CAPR
CAPRICOR THERAPEUTICS, INC.

2017 Q2 Form 10-Q Financial Statement

#000114420417043152 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q4 2016 Q2
Revenue $996.5K $910.0K $1.130M
YoY Change -11.8% -18.75% -12.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.250M $1.150M $1.430M
YoY Change -12.59% 6.48% 53.76%
% of Gross Profit
Research & Development $3.128M $2.670M $4.308M
YoY Change -27.39% -19.82% 25.71%
% of Gross Profit
Depreciation & Amortization $40.00K $40.00K $40.00K
YoY Change 0.0% 33.33% 33.33%
% of Gross Profit
Operating Expenses $4.375M $3.820M $5.742M
YoY Change -23.81% -13.38% 31.91%
Operating Profit -$3.379M -$4.612M
YoY Change -26.75% 50.65%
Interest Expense $105.5K -$100.0K $76.89K
YoY Change 37.25% 66.67% 24.65%
% of Operating Profit
Other Income/Expense, Net -$93.48K -$76.46K
YoY Change 22.25% 24.27%
Pretax Income -$3.470M -$4.520M -$4.690M
YoY Change -26.01% 34.93% 50.32%
Income Tax
% Of Pretax Income
Net Earnings -$3.472M -$4.520M -$4.689M
YoY Change -25.95% 34.93% 50.13%
Net Earnings / Revenue -348.45% -496.7% -415.01%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.570M -$2.112M -$2.606M
COMMON SHARES
Basic Shares Outstanding 22.60M shares 21.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q4 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.26M $16.19M $11.35M
YoY Change 8.0% 19.37% -44.72%
Cash & Equivalents $8.261M $3.204M $8.851M
Short-Term Investments $3.999M $12.99M $2.500M
Other Short-Term Assets $1.070M $1.690M $240.0K
YoY Change 345.83% 704.76% -67.12%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.64M $18.11M $11.81M
YoY Change 15.51% 29.44% -45.44%
LONG-TERM ASSETS
Property, Plant & Equipment $399.0K $435.3K $355.3K
YoY Change 12.31% 36.65% 35.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $60.00K $60.00K $60.00K
YoY Change 0.0% -14.29% -14.29%
Total Long-Term Assets $578.1K $639.0K $2.083M
YoY Change -72.25% -69.27% 1.74%
TOTAL ASSETS
Total Short-Term Assets $13.64M $18.11M $11.81M
Total Long-Term Assets $578.1K $639.0K $2.083M
Total Assets $14.22M $18.75M $13.89M
YoY Change 2.35% 16.66% -41.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.490M $3.530M $3.470M
YoY Change -28.24% 22.57% 7.76%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $14.16M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.64M $4.895M $6.205M
YoY Change 168.25% -25.02% -9.6%
LONG-TERM LIABILITIES
Long-Term Debt $3.100M $17.01M $12.16M
YoY Change -74.51% 85.7% 32.75%
Other Long-Term Liabilities $1.060M $850.0K $650.0K
YoY Change 63.08% -40.14% -79.17%
Total Long-Term Liabilities $4.160M $17.86M $12.80M
YoY Change -67.51% 68.88% 4.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.64M $4.895M $6.205M
Total Long-Term Liabilities $4.160M $17.86M $12.80M
Total Liabilities $20.80M $22.75M $19.01M
YoY Change 9.45% 33.03% -0.67%
SHAREHOLDERS EQUITY
Retained Earnings -$61.12M -$53.98M -$44.13M
YoY Change 38.5% 53.47%
Common Stock $54.52M $49.97M $39.01M
YoY Change 39.78% 46.41% 16.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.586M -$4.003M -$5.116M
YoY Change
Total Liabilities & Shareholders Equity $14.22M $18.75M $13.89M
YoY Change 2.35% 16.66% -41.36%

Cashflow Statement

Concept 2017 Q2 2016 Q4 2016 Q2
OPERATING ACTIVITIES
Net Income -$3.472M -$4.520M -$4.689M
YoY Change -25.95% 34.93% 50.13%
Depreciation, Depletion And Amortization $40.00K $40.00K $40.00K
YoY Change 0.0% 33.33% 33.33%
Cash From Operating Activities -$3.690M -$3.470M -$4.880M
YoY Change -24.39% -4.93% 159.57%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$100.0K -$30.00K
YoY Change -33.33% 50.0%
Acquisitions
YoY Change
Other Investing Activities $5.000M -$10.49M $0.00
YoY Change -309.8%
Cash From Investing Activities $4.980M -$10.59M -$30.00K
YoY Change -16700.0% -312.22% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.930M 0.000 2.000M
YoY Change 96.5%
NET CHANGE
Cash From Operating Activities -3.690M -3.470M -4.880M
Cash From Investing Activities 4.980M -10.59M -30.00K
Cash From Financing Activities 3.930M 0.000 2.000M
Net Change In Cash 5.220M -14.06M -2.910M
YoY Change -279.38% -1149.25% 52.36%
FREE CASH FLOW
Cash From Operating Activities -$3.690M -$3.470M -$4.880M
Capital Expenditures -$20.00K -$100.0K -$30.00K
Free Cash Flow -$3.670M -$3.370M -$4.850M
YoY Change -24.33% -7.67% 160.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
342892 USD
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
239331 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
18108340 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
13640187 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
435336 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
142253 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
117879 USD
CY2017Q2 us-gaap Assets
Assets
14218267 USD
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2177280 USD
CY2016Q4 capr Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
489217 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1367186 USD
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4895183 USD
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16644327 USD
CY2016Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
13905857 USD
CY2017Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
0 USD
CY2016Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
849469 USD
CY2017Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1060316 USD
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
17855326 USD
CY2017Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4160316 USD
CY2016Q4 us-gaap Liabilities
Liabilities
22750509 USD
CY2017Q2 us-gaap Liabilities
Liabilities
20804643 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
49951165 USD
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
54501710 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3524 USD
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7317 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-4003154 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-6586376 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18747355 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14218267 USD
CY2016Q4 us-gaap Other Assets
OtherAssets
61426 USD
CY2017Q2 us-gaap Other Assets
OtherAssets
61166 USD
CY2016Q4 us-gaap Assets
Assets
18747355 USD
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3038780 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
399035 USD
CY2017Q2 capr Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
311190 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61117998 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53979242 USD
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
828569 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1347225 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
22595 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
21399 USD
CY2017Q2 us-gaap Grants Receivable Current
GrantsReceivableCurrent
312870 USD
CY2016Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
223335 USD
CY2017Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
3100000 USD
CY2016Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
3100000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
869880 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
65097 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76055 USD
us-gaap Share Based Compensation
ShareBasedCompensation
944611 USD
us-gaap Share Based Compensation
ShareBasedCompensation
869880 USD
us-gaap Interest Paid
InterestPaid
1343 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3681861 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4537863 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3282823 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
986 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
250000 USD
CY2016Q4 capr Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
16200000 USD
CY2017Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
9089466 USD
CY2016Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
8851129 USD
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
43276 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
43733 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4330 USD
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
800000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1300000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24375 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24375 USD
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1500000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7732632 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8177295 shares
CY2017Q2 us-gaap Marketable Securities
MarketableSecurities
3998520 USD
CY2015Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
17957 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
436212 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
143490 USD
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
292722 USD
CY2016Q4 capr Disbursement Amount Under Grant Award
DisbursementAmountUnderGrantAward
1100000 USD
CY2017Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
12700000 USD
capr Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
capr Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
0
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1081716 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1081903 shares
capr Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
187 shares
capr Class Of Warrant Or Right Expired Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice
2.27
capr Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
0 shares
capr Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
0
CY2016Q4 capr Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
4.01
CY2017Q2 capr Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
4.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.00
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
654025 USD
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22595310 shares
CY2016Q1 capr Warrant Redemption Weighted Average Common Stock Per Share Threshold Limit
WarrantRedemptionWeightedAverageCommonStockPerShareThresholdLimit
7.50
CY2016Q1 capr Warrant Redemption Fees Per Share
WarrantRedemptionFeesPerShare
0.001
CY2017Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
30000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
171803 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
147429 USD
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21399019 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21399019 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3681861 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
0 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
1769 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.25in"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting period. The most sensitive estimates relate to&#160;&#160;recoverability and fair value of intangible assets and the assumptions used to estimate stock-based compensation expense. Management uses its historical records and knowledge of its business in making these estimates. Accordingly, actual results may differ from these estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
686013 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2165 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24375 USD
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8177295 shares
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7732632 shares
CY2017Q2 capr Liquidity Damage Obligation Description
LiquidityDamageObligationDescription
The Company will be required to pay to each Investor liquidated damages equal to 1.0% of the aggregate purchase price paid by such Investor pursuant to the Subscription Agreements for the shares per month (up to a cap of 10.0%) if it does not meet certain obligations with respect to the registration of the shares, subject to certain conditions.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.81
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.78
CY2017Q2 us-gaap Loans Payable Current
LoansPayableCurrent
14155857 USD
CY2016Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0 USD
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5568306 USD
CY2016Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8851129 USD
CY2017Q2 capr Sharebased Compensation Arrangement By Sharebased Payment Award Available For Grant
SharebasedCompensationArrangementBySharebasedPaymentAwardAvailableForGrant
6300000 USD

Files In Submission

Name View Source Status
0001144204-17-043152-index-headers.html Edgar Link pending
0001144204-17-043152-index.html Edgar Link pending
0001144204-17-043152.txt Edgar Link pending
0001144204-17-043152-xbrl.zip Edgar Link pending
capr-20170630.xml Edgar Link completed
capr-20170630.xsd Edgar Link pending
capr-20170630_cal.xml Edgar Link unprocessable
capr-20170630_def.xml Edgar Link unprocessable
capr-20170630_lab.xml Edgar Link unprocessable
capr-20170630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v472518_10-q.htm Edgar Link pending
v472518_ex31-1.htm Edgar Link pending
v472518_ex31-2.htm Edgar Link pending
v472518_ex32-1.htm Edgar Link pending
v472518_ex32-2.htm Edgar Link pending